Astrocytic BAG3 regulates protein clearance systems linked to Alzheimer disease
Loss of the chaperone mediator in human astrocytes disrupts autophagy, proteasomes, and retromer traffic while impairing amyloid-beta proteostasis in neuron cocultures.
Proceedings of the National Academy of Sciences of the United States of America · Augur ZM et al. · Paper published 28 Sep 2026
In human cell models and postmortem human brain tissue, researchers investigated how Bcl-2-associated athanogene 3 (BAG3) influences astrocyte biology and Alzheimer's disease. Using CRISPR/Cas9-edited human induced pluripotent stem cells, the team found that BAG3 loss disrupted astrocytes more severely than neurons. The deficient astrocytes showed reduced autophagy, diminished lysosomal abundance and activity, and compromised proteasome function. Coimmunoprecipitation revealed that BAG3 binds proteasome regulators, HSPB8, and the retromer complex component VPS35. BAG3 deficiency altered retromer function, affecting amyloid precursor protein localization in endosomes, and deregulated disease-relevant proteins including GFAP and BIN1. Coculturing BAG3-knockout astrocytes with mutant neurons impaired amyloid-beta proteostasis. In postmortem human brains, BAG3 marked a stress-responsive astrocyte subtype in aged individuals.
Why it matters
Proteostasis decline is a primary feature of brain aging and neurodegeneration. Identifying BAG3 as a coordinator of multiple clearance pathways in astrocytes highlights how non-neuronal cells maintain protein quality control in the aging brain.
Caveats
The functional experiments were conducted in cultured stem-cell-derived cells rather than in living model organisms. In addition, the findings in aged humans rely on observational analyses of postmortem brain tissue.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
BAG3 coordinates astrocytic proteostasis of Alzheimer's disease-linked proteins via proteasome, autophagy, and retromer interactions
Augur ZM, Fogo GM, Benoit CR et al.
Proceedings of the National Academy of Sciences of the United States of America · 28 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Important
- Evidence
- Cells
- Status
- Peer-reviewed
More on Brain aging
See allHuman neurons accumulate far more mutations over lifespan than shorter-lived mammals
Cortical neurons gain mutations at similar yearly rates across six species, leaving aged humans with uniquely high mutational burdens and transcriptomic dysregulation.
bioRxiv : the preprint server for biology · Caglayan E et al.
CAR T cells targeting inflammatory bone marrow progenitors restore cognition in aged mice
Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.
bioRxiv · Harris AS et al.
Extracellular cGAMP drives neuroinflammation and premature aging phenotypes in mice
Loss of the cGAMP-degrading enzyme ENPP1 allows microglia-derived signaling molecules to trigger STING-dependent inflammation across multiple brain cell types.
bioRxiv · R. Carvalho D et al.
Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease
The three-dimensional cell platform maintains biological aging markers while spontaneously developing hallmark pathologies of sporadic Alzheimer disease.
bioRxiv · Alsolami S et al.
Auditory nerve myelin degeneration defines a subtype of age-related hearing loss
Researchers linked poor auditory nerve synchrony and myelin degradation to amplified communication difficulties in older humans, beyond standard hearing thresholds.
medRxiv : the preprint server for health sciences · Harris KC et al.